医療分野における生成型AI市場規模、成長と動向分析レポート 2026-2033年

世界の医療分野における生成型AI市場規模は、2025年に29億米ドルと推定され、2033年には282億米ドルに成長し、2026年から2033年にかけての年平均成長率（CAGR）は33.3%に達するとGrand View Researchでは予測しています。
生成型AIは、データに基づいた洞察を提供することで、患者ケアの向上、診断精度の向上、臨床ワークフローの効率化を実現し、医療を変革しています。

主要市場動向と洞察

• 北米の医療分野における生成型AI市場は、2025年時点で世界市場の41.0%以上を占め、最大のシェアを獲得しました。
• 米国の医療分野における生成型AI業界は、予測期間中に大幅な成長が見込まれています。
• コンポーネント別に見ると、ソリューション分野が2025年に71.2%と最大の市場シェアを占める見込みです。
• 機能別に見ると、管理プロセス最適化分野が2025年に32.9%と最大の市場シェアを占める見込みです。
• アプリケーション別に見ると、臨床分野が2025年に62.1%と最大の市場シェアを占める見込みです。
• エンドユーザー別に見ると、医療センター分野が2025年に44.0%と最大の市場シェアを占める見込みです。

さらに、患者数の増加、高齢化、医療データの複雑化といった要因が、医療市場におけるAIの需要を高めている。

本レポートは、世界、地域、国レベルでの収益成長を予測し、2021年から2033年までの各サブセグメントにおける業界動向を分析しています。本調査において、Grand View Researchは、医療分野における生成型AI市場レポートを、コンポーネント、機能、エンドユース、アプリケーション、地域に基づいてセグメント化しました。

Generative AI In Healthcare Market Summary

Moreover, the rising patient volumes, an aging population, and the increasing complexity of medical data are increasing the demand for AI in the healthcare market.

Market Drivers and Dynamics

The rising demand for personalized healthcare solutions is a key growth driver for the Generative AI in Healthcare Market. Generative AI benefits this trend by enabling tailored treatment plans through advanced data analysis, enhancing diagnostic accuracy, and streamlining administrative tasks. By aggregating and analyzing diverse data sources, including electronic health records (EHRs), genetic information, imaging datasets, and lifestyle factors, generative AI creates comprehensive patient profiles that support individualized care delivery.

In addition, generative AI is emerging as a key driver in healthcare by automating labor-intensive processes, improving clinical efficiency, and reducing physician burnout. One of the most significant applications is ambient documentation, where AI tools capture and structure physician-patient conversations in real time, minimizing administrative workload and enhancing the accuracy of medical records. For instance, in 2024, Kaiser Permanente tested ambient GenAI documentation in a 10-week pilot and, after strong results, expanded it across all eight regions, covering about 600 medical offices and 40 hospitals by 2025.

In addition, Northwestern Medicine rolled out DAX Copilot in Epic across its enterprise in August 2024, becoming an early mover in the large-scale integration of generative AI into clinical workflows. These deployments highlight a decisive shift from trials to system-wide adoption, signaling growing confidence in generative AI’s ability to streamline healthcare operations and drive the growth of the generative AI in healthcare industry.

Furthermore, the integration of AI-driven documentation tools into leading EHR platforms has been a major catalyst for adoption, as it streamlines physician workflows, minimizes manual data entry, improves documentation accuracy, and reduces burnout, ultimately enabling enterprise-wide deployment of generative AI across health systems. For instance, in 2024, Microsoft (Nuance) and Epic expanded the availability of DAX Copilot, embedding generative AI directly into Epic’s workflows.

More than 150 health systems were named as adopters, including large providers such as Lifespan and UNC Health. Several moved beyond pilots to enterprise deployment, with Northwestern Medicine confirming a full rollout in August 2024. Intermountain Health and Overlake Medical Center also implemented DAX Copilot during the same year. These large-scale deployments demonstrate how embedding generative AI into widely used EHRs accelerates adoption, reduces integration barriers, and reinforces the technology’s potential to drive market growth.

Market Concentration & Characteristics

The chart below illustrates the relationship between industry concentration, characteristics, and participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, levels of partnerships & collaboration, degree of innovation, impact of regulations, and regional expansion. The generative AI in healthcare market is fragmented, with the presence of several emerging solution providers dominating the market. The degree of innovation is high, and the level of partnerships & collaboration activities is moderate. The impact of regulations on industry and the regional expansion of the industry is high.

The generative AI in healthcare industry experiences a high degree of innovation driven by technological advancements. The increasing adoption of healthcare IT solutions in revenue cycle management, drug discovery, personalized treatments, and hospital administration supports innovations in the market. For instance, in February 2025, Innovaccer launched Agents of Care-a suite of pre-trained AI Agents. This suite is expected to alleviate the strain of administrative overload in healthcare.

The industry is experiencing moderate levels of merger and acquisition activity driven by several key players. This is due to the desire to gain a competitive advantage in the industry, enhance technological capabilities, and consolidate in a rapidly growing market.

Regulations, such as the HIPAA in the U.S. and the GDPR in Europe, establish standards for safeguarding patient data privacy and security. Compliance with these regulations is crucial for AI applications in healthcare to ensure the safe and secure handling of patient information, reducing the risk of data breaches and unauthorized access.

Companies within the generative AI sector seek geographic expansion strategies to maintain their foothold in emerging markets and attract customers from these regions. Moreover, the industry is witnessing moderate geographical expansion, driven by an increasing customer base for generative AI software. With the growing adoption of digital healthcare solutions, the market is expected to grow significantly in the coming years, especially in developing countries.

Component Insights

The solutions segment dominated the generative AI in healthcare market, accounting for 71.2% of revenue in 2025. The rising demand for faster, more accurate diagnosis and the rapid expansion of drug discovery and personalized medicine are driving the segment’s growth. Pharmaceutical and biotechnology companies are increasingly using generative AI platforms to design novel drug molecules, predict outcomes, and optimize clinical trials. These solutions significantly shorten development timelines and lower R&D costs, creating strong demand from life sciences organizations.

In July 2025, Mayo Clinic deployed NVIDIA Blackwell-powered DGX SuperPOD infrastructure to accelerate generative AI, foundation model development for digital pathology, and precision medicine initiatives, thereby enhancing clinical innovation and operational efficiency.

“This compute power, coupled with Mayo’s unparalleled clinical expertise and platform data of over 20 million digitized pathology slides, will allow Mayo to build on its existing foundation models. We’re transforming healthcare by quickly and safely developing innovative AI solutions that can improve patient outcomes and enable clinicians to dedicate more time to patient care while also accelerating commercial affiliations with other industry leaders.” – Jim Rogers, CEO of Mayo Clinic Digital Pathology.

The service segment is expected to grow at the fastest CAGR during the forecast period. The demand for the services segment is increasing due to the complexity of AI deployment, rising cybersecurity concerns, regulatory requirements, and the need for customized solutions. Many healthcare organizations lack in-house AI expertise, making external service providers critical partners in digital transformation initiatives. As generative AI adoption expands, the Services segment continues to grow alongside the Solutions segment, supporting sustainable and scalable implementation across the healthcare ecosystem.

Function Insights

The administrative process optimization segment dominated the generative AI in healthcare industry with a revenue share of 32.9% in 2025. Administrative process optimization is a significant function segment in the generative AI healthcare market, focusing on the automation and enhancement of non-clinical workflows. Unlike clinical applications, this segment directly addresses operational inefficiencies, enabling healthcare providers to reduce administrative burdens while improving service quality.

The medical imaging analysis segment is expected to grow at the fastest CAGR from 2026 to 2033. This segment focuses on the automated interpretation, enhancement, and generation of medical images. This segment leverages AI models to analyze imaging data from X-rays, CT scans, MRIs, and ultrasounds, enabling faster, more accurate diagnoses than conventional methods.

Application Insights

The clinical segment dominated the generative AI in the healthcare industry with a revenue share of 62.1% in 2025. In addition, this segment is anticipated to grow at the fastest CAGR during the forecast period. The clinical segment of the generative AI healthcare market is seeing rising demand as healthcare providers are seeking technologies that improve diagnostic accuracy and patient outcomes. Advancements in AI technologies, large language models, and medical imaging algorithms have further accelerated the adoption of generative AI in clinical applications. Improved computing power and access to large healthcare datasets have made these tools more accurate and reliable for real-world clinical use.

The system segment is expected to grow significantly during the forecast period. This segment is gaining demand as healthcare organizations increasingly focus on improving hospital management and operational efficiency. Healthcare systems handle a large amount of operational data related to patient admissions, scheduling, supply chain management, and hospital resources. Generative AI helps streamline these system-level processes by generating insights, automating workflows, and improving coordination across different departments. This enables healthcare institutions to operate more efficiently and manage resources more effectively.

End Use Insights

The medical centers segment dominated the generative AI in healthcare market, with the largest revenue share of 44.0% in 2025. Medical centers are increasingly adopting generative AI to enhance patient care, operational efficiency, and research capabilities. For instance, in February 2026, Japan Community Healthcare Organization Osaka Hospital, in collaboration with Fujitsu Japan Limited and Microsoft Japan Co., Ltd., launched a generative AI project to enhance clinical documentation, workforce efficiency, and governance frameworks across hospital operations.

The clinical research segment is projected to grow at the fastest CAGR from 2026 to 2033. The demand for generative AI in clinical research is increasing rapidly due to its ability to accelerate and optimize the drug development process. Another factor driving demand is improved patient recruitment and retention. Identifying eligible patients for clinical trials has often been a bottleneck. Generative AI can analyze electronic health records to find suitable candidates, predict dropout risks, and suggest engagement strategies. These capabilities enable trials to recruit participants more efficiently and maintain higher retention rates, thereby improving the likelihood of trial success.

Key Generative AI in Healthcare Company Insights

The market is characterized by strong competition, with a few major worldwide competitors owning a significant market share. The major focus is on developing new products and collaborating among the key players. For instance, in May 2023, DiagnaMed Holdings Corp., a biotechnology company in Canada unveiled FormGPT.io, a generative AI data analysis solution tailored for the healthcare sector. This launch represents the company’s first commercial product in its effort to release a suite of customizable applications utilizing the power of GPT-4. These applications are designed to improve patient outcomes and streamline operations in real-world healthcare settings. These applications are designed to improve patient outcomes and streamline operations in real-world healthcare settings.

Recent Developments

• In October 2025, Microsoft expanded Dragon Copilot with ambient and generative AI capabilities for nursing workflows and partner integrations, enhancing clinical intelligence, revenue cycle management and patient care efficiency.

“Microsoft continues to advance Dragon Copilot as a leading enterprise-wide AI clinical assistant for healthcare provider organizations, now adding support for specialized nursing workflows and an ecosystem of third-party AI extensions.” -Mary Varghese Presti, CVP and Chief Operating Officer, Microsoft Health and Life Sciences.

• In August 2025, Epic unveiled new AI capabilities across its EHR platform, including generative AI tools for clinical documentation, revenue cycle management and patient engagement, and previewed Cosmos AI for predictive risk modeling.
• In July 2025, Omega Healthcare expanded its collaboration with Microsoft to integrate Azure AI Foundry and Azure OpenAI capabilities into its Omega Digital Platform (ODP), launching more than 20 generative and agentic AI solutions to automate and optimize end-to-end revenue cycle management (RCM) operations for healthcare providers and payers.

“We are bringing scalable, tech-enabled services without requiring healthcare leaders to take on large, risky technology investments, freeing them up to focus on what matters most – delivering exceptional patient care.” -Anurag Mehta, CEO and Co-Founder, Omega Healthcare

• In March 2024, NVIDIA Healthcare launched over 25 generative AI microservices, including NIM and CUDA-X tools, enabling pharmaceutical, biotech and healthcare organizations to accelerate drug discovery, genomics, imaging and digital health workflows.

“Generative AI is transforming drug discovery by allowing us to build sophisticated models and seamlessly integrate AI into the antibody design process.” -David M. Reese, executive vice president and chief technology officer at Amgen. 

Global Generative AI In Healthcare Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the generative AI in healthcare market report based on component, function, end use, application, and region:

• Component Outlook (Revenue, USD Million, 2021 – 2033)
  • Solutions
  • Service
• Function Outlook (Revenue, USD Million, 2021 – 2033)
  • Virtual Nursing Assistants
  • Robot-Assisted AI Surgery
  • Administrative Process Optimization
  • Medical Imaging Analysis
• End Use Outlook (Revenue, USD Million, 2021 – 2033)
  • Clinical Research
  • Medical Centers
  • Diagnostic Centers
  • Others
• Application Outlook (Revenue, USD Million, 2021 – 2033)
  • Clinical
  • System
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Function Segment
1.2.3. Application
1.2.4. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Generative AI in Healthcare Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Industry Challenge Analysis
3.2.4. Industry Opportunity Analysis
3.3. Generative AI in Healthcare Market Analysis Tools
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political Landscape
3.3.2.2. Economic Landscape
3.3.2.3. Social Landscape
3.3.2.4. Technology Landscape
3.3.2.5. Environmental Landscape
3.3.2.6. Legal Landscape
3.4. Use Cases Analysis
Chapter 4. Generative AI in Healthcare Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Generative AI in Healthcare Market: Component Movement Analysis, USD Million, 2025 & 2033
4.3. Solutions
4.3.1. Solutions Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
4.4. Services
4.4.1. Services Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 5. Generative AI in Healthcare Market: Function Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Generative AI in Healthcare Market: Function Movement Analysis, USD Million, 2025 & 2033
5.3. Virtual Nursing Assistants
5.3.1. Virtual Nursing Assistants Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.4. Robot-Assisted AI Surgery
5.4.1. Robot-Assisted AI Surgery Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.5. Administrative Process Optimization
5.5.1. Administrative Process Optimization Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
5.6. Medical Imaging Analysis
5.6.1. Medical Imaging Analysis Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 6. Generative AI in Healthcare Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Generative AI in Healthcare Market: End Use Movement Analysis, USD Million, 2025 & 2033
6.3. Clinical Research
6.3.1. Clinical Research Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
6.4. Medical Centers
6.4.1. Medical Centers Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
6.5. Diagnostic Centers
6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 7. Generative AI in Healthcare Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Generative AI in Healthcare Market: Application Movement Analysis, USD Million, 2025 & 2033
7.3. Clinical
7.3.1. Clinical Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
7.4. System
7.4.1. System Market Revenue Estimates and Forecasts, 2021 – 2033 (USD Million)
Chapter 8. Generative AI in Healthcare Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
9.4.1. NVIDIA Corporation
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. Google LLC
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. IBM
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Johnson & Johnson
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Microsoft Corporation
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Oracle
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Tencent Holdings Ltd
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Neuralink Corporation
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. NioyaTech
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. OpenAI
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Saxon
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Syntegra
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global Generative AI in Healthcare market, by region, 2021 – 2033 (USD Million)
Table 3 Global Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 4 Global Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 5 Global Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 6 Global Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 7 North America Generative AI in Healthcare market, by country, 2021 – 2033 (USD Million)
Table 8 North America Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 9 North America Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 10 North America Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 11 North America Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 12 U.S. Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 13 U.S. Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 14 U.S. Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 15 U.S. Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 16 Canada Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 17 Canada Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 18 Canada Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 19 Canada Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 20 Mexico Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 21 Mexico Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 22 Mexico Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 23 Mexico Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 24 Europe Generative AI in Healthcare market, by country, 2021 – 2033 (USD Million)
Table 25 Europe Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 26 Europe Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 27 Europe Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 28 Europe Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 29 UK Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 30 UK Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 31 UK Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 32 UK Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 33 Germany Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 34 Germany Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 35 Germany Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 36 Germany Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 37 France Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 38 France Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 39 France Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 40 France Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 41 Italy Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 42 Italy Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 43 Italy Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 44 Italy Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 45 Spain Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 46 Spain Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 47 Spain Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 48 Spain Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 49 Denmark Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 50 Denmark Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 51 Denmark Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 52 Denmark Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 53 Sweden Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 54 Sweden Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 55 Sweden Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 56 Sweden Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 57 Norway Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 58 Norway Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 59 Norway Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 60 Norway Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 61 Asia Pacific Generative AI in Healthcare market, by country, 2021 – 2033 (USD Million)
Table 62 Asia Pacific Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 63 Asia Pacific Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 64 Asia Pacific Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 65 Asia Pacific Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 66 China Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 67 China Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 68 China Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 69 China Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 70 Japan Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 71 Japan Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 72 Japan Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 73 Japan Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 74 India Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 75 India Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 76 India Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 77 India Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 78 South Korea Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 79 South Korea Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 80 South Korea Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 81 South Korea Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 82 Australia Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 83 Australia Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 84 Australia Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 85 Australia Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 86 Thailand Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 87 Thailand Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 88 Thailand Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 89 Thailand Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 90 Latin America Generative AI in Healthcare market, by country, 2021 – 2033 (USD Million)
Table 91 Latin America Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 92 Latin America Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 93 Latin America Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 94 Latin America Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 95 Brazil Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 96 Brazil Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 97 Brazil Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 98 Brazil Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 99 Argentina Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 100 Argentina Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 101 Argentina Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 102 Argentina Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 103 Middle East & Africa Generative AI in Healthcare market, by country, 2021 – 2033 (USD Million)
Table 104 Middle East & Africa Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 105 Middle East & Africa Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 106 Middle East & Africa Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 107 Middle East & Africa Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 108 South Africa Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 109 South Africa Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 110 South Africa Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 111 South Africa Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 112 Saudi Arabia Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 113 Saudi Arabia Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 114 Saudi Arabia Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 115 Saudi Arabia Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 116 UAE Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 117 UAE Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 118 UAE Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 119 UAE Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)
Table 120 Kuwait Generative AI in Healthcare market, by component, 2021 – 2033 (USD Million)
Table 121 Kuwait Generative AI in Healthcare market, by function, 2021 – 2033 (USD Million)
Table 122 Kuwait Generative AI in Healthcare market, by end use, 2021 – 2033 (USD Million)
Table 123 Kuwait Generative AI in Healthcare market, by application, 2021 – 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Market formulation & validation
Fig. 4 Generative AI in Healthcare market: Market outlook
Fig. 5 Generative AI in Healthcare market: Segment outlook
Fig. 6 Generative AI in Healthcare market: Competitive landscape outlook
Fig. 7 Parent market outlook
Fig. 8 Generative AI in Healthcare market driver impact
Fig. 9 Generative AI in Healthcare market restraint impact
Fig. 10 Generative AI in Healthcare market: Component outlook and key takeaways
Fig. 11 Generative AI in Healthcare market: Component movement analysis
Fig. 12 Solutions market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 13 Service market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 14 Generative AI in Healthcare market: Function outlook and key takeaways
Fig. 15 Generative AI in Healthcare market: Function movement analysis
Fig. 16 Virtual Nursing Assistants market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 17 Robot-Assisted AI Surgery market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 18 Administrative Process Optimization market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 19 Medical Imaging Analysis market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 20 Generative AI in Healthcare market: End-use outlook and key takeaways
Fig. 21 Generative AI in Healthcare market: End-use movement analysis
Fig. 22 Clinical Research market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 23 Medical Centers market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 24 Diagnostic Centers market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 25 Others market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 26 Generative AI in Healthcare market: Application outlook and key takeaways
Fig. 27 Generative AI in Healthcare market: Application movement analysis
Fig. 28 Clinical market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 29 System market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 30 Global Generative AI in Healthcare market: Regional outlook and key takeaways
Fig. 31 Global Generative AI in Healthcare market: Regional movement analysis
Fig. 32 North America market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 33 U.S. key country dynamics
Fig. 34 U.S. market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 35 Canada key country dynamics
Fig. 36 Canada market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 37 Mexico key country dynamics
Fig. 38 Mexico market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 39 Europe market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 40 UK key country dynamics
Fig. 41 UK market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 42 Germany key country dynamics
Fig. 43 Germany market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 44 France key country dynamics
Fig. 45 France market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 46 Italy key country dynamics
Fig. 47 Italy market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 48 Spain key country dynamics
Fig. 49 Spain market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 50 Denmark key country dynamics
Fig. 51 Denmark market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 52 Sweden key country dynamics
Fig. 53 Sweden market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 54 Norway key country dynamics
Fig. 55 Norway market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 56 Asia Pacific market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 57 Japan key country dynamics
Fig. 58 Japan market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 59 China key country dynamics
Fig. 60 China market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 61 India key country dynamics
Fig. 62 India market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 63 Thailand key country dynamics
Fig. 64 Thailand market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 65 South Korea key country dynamics
Fig. 66 South Korea market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 67 Australia key country dynamics
Fig. 68 Australia market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 69 Latin America market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 70 Brazil key country dynamics
Fig. 71 Brazil market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 72 Argentina key country dynamics
Fig. 73 Argentina market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 74 Middle East and Africa market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 75 South Africa key country dynamics
Fig. 76 South Africa market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 77 Saudi Arabia key country dynamics
Fig. 78 Saudi Arabia market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 79 UAE key country dynamics
Fig. 80 UAE market estimates and forecasts, 2021 – 2033 (USD Million)
Fig. 81 Kuwait key country dynamics
Fig. 82 Kuwait market estimates and forecasts, 2021 – 2033 (USD Million)

---

---